COVID-19 (Novel Coronavirus) (DynaMed)

Item request has been placed!

Item request cannot be made.

Processing Request

Read Online

Domain:

Health

Keywords:

experimental drugs, Treatment, CPAP, Testing, Influenza, antimalarial, chloroquine, Diagnosis, Mask, NIPPV, Therapy, antiviral drugs, remdesivir, ACE, Pneumonia, ARB, ventilator, Gloves, pregnancy, Plaquenil, convalescent plasma, HCQ, triage, BiPAP, clinical trial, Personal Protective Equipment (PPE), hydroxychloroquine, Screening, ACEI, pregnant, Review/Reference, Critical Care, Emergency Medicine, Hospital Medicine, Infectious Diseases, Internal Medicine, Pulmonary Medicine, Healthcare Professionals, EBSCO & Partners, Trusted Publisher, Health, covid2019-nCoV, Novel Coronavirus, SARS-CoV-2, WN-CoV, Wuhan Virus, Wuhan novel coronavirus, coronavirus, china virus, china flu, wuhan flu, C19, C-19, coronaviridae, betacoronavirus, covid19, covid, ncov, cov2, cov-2, cov 2, sarcov2, 2019nCoV, hubei outbreak, huanan outbreak, huanan virus, hubei virus, 2019-nCoV, 2019 pandemic, 2020 pandemic, pandemic 2019, pandemic 2020, PMIS, PMIS-C, MIS, MIS-C, hydroxychloroquine, remdesivir

Tags:

hydroxychloroquine, remdesivir

Description:

acute respiratory disease caused by a novel coronavirus (SARS-CoV-2) first identified in December 2019 in Wuhan, Hubei Province, China and spreading worldwide. SARS-CoV-2 is a member of beta genus coronaviruses closely related to SARS-CoV

Collection:

COVID-19 Information

Type of Resource:

Clinical Reference

Country:

All (global)

Medical Specialty:

Critical Care

Emergency Medicine

Hospital Medicine

Infectious Diseases

Internal Medicine

Pulmonary Medicine

For:

Healthcare Professionals

Source:

EBSCO & Partners

Trusted Publisher